These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 16170357)

  • 1. Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression.
    Bossi G; Lapi E; Strano S; Rinaldo C; Blandino G; Sacchi A
    Oncogene; 2006 Jan; 25(2):304-9. PubMed ID: 16170357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells.
    Anthoney DA; McIlwrath AJ; Gallagher WM; Edlin AR; Brown R
    Cancer Res; 1996 Mar; 56(6):1374-81. PubMed ID: 8640828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant p53 protein expression interferes with p53-independent apoptotic pathways.
    Li R; Sutphin PD; Schwartz D; Matas D; Almog N; Wolkowicz R; Goldfinger N; Pei H; Prokocimer M; Rotter V
    Oncogene; 1998 Jun; 16(25):3269-77. PubMed ID: 9681825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.
    Fricke E; Hermannstädter C; Keller G; Fuchs M; Brunner I; Busch R; Höfler H; Becker KF; Luber B
    Oncology; 2004; 66(2):150-9. PubMed ID: 15138368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil.
    Pugacheva EN; Ivanov AV; Kravchenko JE; Kopnin BP; Levine AJ; Chumakov PM
    Oncogene; 2002 Jul; 21(30):4595-600. PubMed ID: 12096336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted cytotoxic somatostatin analogue AN-238 inhibits somatostatin receptor-positive experimental colon cancers independently of their p53 status.
    Szepeshazi K; Schally AV; Halmos G; Armatis P; Hebert F; Sun B; Feil A; Kiaris H; Nagy A
    Cancer Res; 2002 Feb; 62(3):781-8. PubMed ID: 11830533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1A gene.
    Sánchez-Prieto R; Quintanilla M; Cano A; Leonart ML; Martin P; Anaya A; Ramón y Cajal S
    Oncogene; 1996 Sep; 13(5):1083-92. PubMed ID: 8806698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAR1, a human anti-p53 single-chain antibody, restores tumor suppressor function to mutant p53 variants.
    Orgad S; Dimant H; Dor-On E; Azriel-Rosenfeld R; Benhar I; Solomon B
    J Immunother; 2010; 33(2):146-54. PubMed ID: 20139776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown.
    Puca R; Nardinocchi L; Gal H; Rechavi G; Amariglio N; Domany E; Notterman DA; Scarsella M; Leonetti C; Sacchi A; Blandino G; Givol D; D'Orazi G
    Cancer Res; 2008 May; 68(10):3707-14. PubMed ID: 18483253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
    Cook JL; Miura TA; Iklé DN; Lewis AM; Routes JM
    Cancer Res; 2003 Jun; 63(12):3435-43. PubMed ID: 12810682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gal-3 is stimulated by gain-of-function p53 mutations and modulates chemoresistance in anaplastic thyroid carcinomas.
    Lavra L; Ulivieri A; Rinaldo C; Dominici R; Volante M; Luciani E; Bartolazzi A; Frasca F; Soddu S; Sciacchitano S
    J Pathol; 2009 May; 218(1):66-75. PubMed ID: 19199318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line.
    Chan KT; Lung ML
    Cancer Chemother Pharmacol; 2004 Jun; 53(6):519-26. PubMed ID: 15004724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression.
    Kotchetkov R; Driever PH; Cinatl J; Michaelis M; Karaskova J; Blaheta R; Squire JA; Von Deimling A; Moog J; Cinatl J
    Int J Oncol; 2005 Oct; 27(4):1029-37. PubMed ID: 16142320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between p53 status and anticancer drugs-induced apoptosis in nine human bladder cancer cell lines.
    Chang FL; Lai MD
    Anticancer Res; 2000; 20(1A):351-5. PubMed ID: 10769679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.
    Wang X; Yuan S; Wang J; Lin P; Liu G; Lu Y; Zhang J; Wang W; Wei Y
    Toxicol Appl Pharmacol; 2006 Sep; 215(2):168-78. PubMed ID: 16563451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53.
    Loging WT; Reisman D
    Oncogene; 1999 Dec; 18(52):7608-15. PubMed ID: 10602522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of novel tumour-derived p53 mutations on the transformation of NIH-3T3 cells.
    Donninger H; Binder A; Bohm L; Parker MI
    Biol Chem; 2008 Jan; 389(1):57-67. PubMed ID: 18095870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
    Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S
    Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.